Abstract
The diagnosis of primary breast lymphoma (PBL) is limited to patients without evidence of systemic lymphoma or leukemia at the time that the breast lesion is detected. Clinically, the disease should involve only the breast or the breast and ipsilateral lymph nodes. PBL is a rare clinical entity that accounts for less than 1% of all patients with non-Hodgkin lymphoma (NHL) and approximately 1.7% of all patients with extra lymph node NHL.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aviv A, Tadmor T, Polliack A. Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options. Ann Oncol. 2013;24:2236–44.
Cheah CY, Campbell B, Seymour J. Primary breast lymphoma. Cancer Treat Rev. 2014;40:900–8.
Lin YC, Tsai CH, Wu JS, Huang CS, Kuo SH, Lin CW, et al. Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast. A review of 42 primary and second cases in Taiwanese patients. Leuk Lymphoma. 2009;50:918–24.
Yhim HY, Kang HJ, Choi YH, Kim SJ, Kim WS, Chae YS, et al. Clinical outcomes and prognostic factors in patients with breast diffuse large B-cell lymphoma; Consortium for improving Survival of Lymphoma study. BMC Cancer. 2010;10:321.
Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29:1705–12.
Hugh J, Jackson F, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer. 1990;66:2602–11.
Talwakar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32:1299–309.
Nicholson BT, Bhatti RM, Glassman L. Extranodal lymphoma of the breast. Radiol Clin N Am. 2016;54:711–26.
Lyons J, Myles T, Pohlman B, Macklis RM, Crowe J, Crownover RL. Treatment and prognosis of primary breast lymphoma. A review of 13 cases. Am J Clin Pathol. 2000;23:334–6.
Yoshida S, Nakamura N, Sasaki Y, Yoshida S, Yasuda M, Sagara H, et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Mod Pathol. 2005;18:398–405.
Hoffman J, Ohgami RS. Hematolymphoid lesions of the breast. Semin Diagn Pathol. 2017;34:462–9.
Lakhani SR, Ellis IO, Schnitt S, Tan PH, van de Vijver MJ. World Health Organization classification of tumors of the breast. 4th ed. Lyon: IARC Press; 2012.
Koganti SB, Lozada A, Curras E, Shah A. Marginal zone lymphoma of the breast. A diminished role for surgery. Int J Surg Case Rep. 2016;25:4–6.
Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, et al. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2009;20(12):1993–9.
Cohen MS, Petryk M, Varma M, Kozuch PS, Ames ED, Grossbard ML. Non-Hodgkin lymphoma of mucosa-associated lymphoid tissue. Oncologist. 2006;11:1100–17.
Bacon CM, Du M-Q, Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologist. J Clin Pathol. 2007;60:361–72.
Cabras MG, Amichetti M, Nagliati M, Orrù P, Mamusa AM, Angelucci E. Primary non-Hodgkin’s lymphoma of the breast: a report of 11 cases. Haematologica. 2004;89:1527–8.
Ogawa T, Mizutani M, Yabana T, Miyahara S, Murabayashi K. A case of Burkitt’s lymphoma involving both breasts. Breast Cancer. 2005;12:234–7.
Mawson AR, Majumdar S. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt’s lymphoma. Int J Cancer. 2017;141:1849–55.
Faenza M, Ronchi A, Santoriello A, Rubino C, Pieretti G, Guastafierro A, et al. What’s new on primary Hodgkin’s lymphoma of the breast. A case report and review of the literature. Int J Surg Case Rep. 2017;38:149–53.
Schouten JT, Weese JL, Carbone PP. Lymphoma of the breast. Ann Surg. 1981;194:749–53.
Ariad S, Lewis D, Cohen R, Bezwoda WR. Breast lymphoma. A clinical and pathological review and 10-year treatment results. S Afr Med J. 1995;85:85–9.
Ergül N, Güner SI, Sağer S, Huq GE, Ciftçi H, Cermik TF. Bilateral breast involvement of Hodgkin lymphoma revealed by FDG PET/CT. Med Oncol. 2012;29:1105–8.
Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2002;80:19–25.
de Jong D, Vasmel WL, de Boer JP, Verhave G, Barbé E, Casparie MK, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008;300:2030–5.
Erhan Y, Veral A, Kara E, Ozdemir N, Kapkac M, Ozdedeli E. A clinicopathologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis. Breast. 2000;9:52–6.
Ely KA, Tse G, Simpson JF, Clarfeld R, Page DL. Diabetic Mastopathy: A Clinicopathologic Review. Am J Clin Pathol. 2000;113:541–5.
Dialani V, Mani K, Johnson NB. Chronic lymphocytic leukemia involving the breast parenchyma, mimicker of invasive breast cancer: differentiation on Breast MRI. Case Rep Med. 2013;18:1–5.
Green I, Dorfman RF, Rosai J. Breast involvement by extranodal disease: report of seven cases. Am J Surg Pathol. 1997;21:664–8.
Picón-Coronel G, PalmerÃn-Bucio ME, Méndez-Pérez V, Alvarado-Cabrero I. Mammary gland Rosai Dorfman disease. A case report and literature review. Gac Med Mex. 2010;146:212–5.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Alvarado-Cabrero, I. (2018). Hematopoietic Lesions of the Breast. In: Stolnicu, S., Alvarado-Cabrero, I. (eds) Practical Atlas of Breast Pathology . Springer, Cham. https://doi.org/10.1007/978-3-319-93257-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-93257-6_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93256-9
Online ISBN: 978-3-319-93257-6
eBook Packages: MedicineMedicine (R0)